“…In general though, aged murine hematopoietic cells (either BM or PB, and independent of the type of mutation assay) show a 2–3 fold increase in mutation frequency in hematopoiesis compared to young (Dempsey, Pfeiffer, and Morley 1993; Vijg et al 2005; Moehrle et al 2015), which is also in the range of changes in mutation frequency recently reported for human hematopoietic cells, determined via deep-sequencing approaches (Cancer Genome Atlas Research Network 2013; Welch et al 2012; Genovese et al 2014; Jaiswal et al 2014; McKerrell et al 2015; Xie et al 2014; Papaemmanuil et al 2013). Interestingly, while the overall increase in mutation frequencies in blood cells was found to be again in the range of 2–3 fold, a set of genes including DNMT3A, TET2, JAK2, ASXL1, SF3B1 or SRSF2 were frequently mutated, both in aging associated leukemia but also in aging-associated changes in clonality.…”